EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudie

Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock

Charlotte J Van Edom, Francesca Fiorelli, Tim Balthazar, Maria Monteagudo-Vela, Thomas Vanassche, Vasileios F Panoulas, Christophe Vandenbriele

Journal of Thrombosis and Haemostasis · 2025-06 · 23 (6) · 1810-1816

DOI: 10.1016/j.jtha.2025.02.028 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025-06. Verfasst von Charlotte J Van Edom und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Diseases, University Hospitals of Leuven, Leuven, Belgium; Department of Cardiovascular Sciences, University of Leuven, …. Hauptthemen laut MEDLINE: Shock, Cardiogenic, Heart-Assist Devices, Blood Coagulation, Factor Xa Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Managing unfractionated heparin (UFH) during percutaneous mechanical circulatory support for cardiogenic shock (CS) is challenging due to potential discrepancies between coagulation tests. OBJECTIVES: To study the causes and consequences of discrepancies between anti-Xa and activated partial thromboplastin time (APTT) for UFH monitoring during microaxial flow pump support (Impella) for CS. METHODS: We assessed patients in CS supported with Impella in 2 tertiary care centers over 62 months. UFH was titrated based on anti-Xa levels with parallel APTT measurements. In-range anti-Xa levels were considered between 0.20 and 0.30 IU/mL or 0.31 and 0.50IU/mL, and the corresponding APTT values were 40 to 55 seconds and 56 to 80 seconds, respectively. Pearson correlation was calculated between anti-Xa and APTT. Samples with in-range anti-Xa but prolonged APTT were analyzed for abnormalities in international normalized ratio (INR; ≥1.5) and/or fibrinogen (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shock, CardiogenicHeart-Assist DevicesBlood CoagulationFactor Xa InhibitorsFactor XaHumansPartial Thromboplastin TimeMaleFemaleAgedMiddle AgedHeparinAnticoagulantsTreatment OutcomeInternational Normalized RatioPredictive Value of TestsTertiary Care CentersTime FactorsRisk Factors

Stichwörter der Autor:innen

heart assist devicesheparinpartial thromboplastin time

Substanzen

HeparinAnticoagulantsFactor Xa InhibitorsFactor Xa

Autor:innen und Institutionen

  • Department of Cardiovascular Diseases, University Hospitals of Leuven, Leuven, Belgium; Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
  • Department of Cardiology and Cardiac Intensive Care, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Departments of Cardiology and Intensive Care, University Hospital Brussels, Jette, Belgium.
  • Department of Cardiothoracic Surgery, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Department of Cardiology and Cardiac Intensive Care, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK; Heart Center, OLV Aalst, Aalst, Belgium; Division of Anaesthetics, Pain…

Förderung

  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Van Edom, C. J., Fiorelli, F., Balthazar, T., Monteagudo-Vela, M., Vanassche, T., Panoulas, V. F., & Vandenbriele, C. (2025). Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock. Journal of Thrombosis and Haemostasis, 23(6), 1810-1816. https://doi.org/10.1016/j.jtha.2025.02.028

Vancouver

Van Edom CJ, Fiorelli F, Balthazar T, Monteagudo-Vela M, Vanassche T, Panoulas VF, et al. Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock. Journal of Thrombosis and Haemostasis. 2025;23(6):1810-1816. doi:10.1016/j.jtha.2025.02.028

BibTeX
@article{VanEdom2025,
  author = {Van Edom, Charlotte J and Fiorelli, Francesca and Balthazar, Tim and Monteagudo-Vela, Maria and Vanassche, Thomas and Panoulas, Vasileios F and Vandenbriele, Christophe},
  title = {Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  volume = {23},
  number = {6},
  pages = {1810--1816},
  doi = {10.1016/j.jtha.2025.02.028}
}
Kostenlos starten →